Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

(2020) Yushun Wan et al.   JOURNAL OF VIROLOGY

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hypertension and COVID-19

(2020) Ernesto L Schiffrin et al.   AMERICAN JOURNAL OF HYPERTENSION

Response to COVID-19 and ACEI/ARB: NOT ASSOCIATED?

(2020) Ernesto L Schiffrin et al.   AMERICAN JOURNAL OF HYPERTENSION

COVID-19 and ACEI/ARB: NOT ASSOCIATED?

(2020) Adrija Hajra et al.   AMERICAN JOURNAL OF HYPERTENSION

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19

(2020) Peng Zhang et al.   CIRCULATION RESEARCH

Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19

(2020) Gavin Y Oudit et al.   EUROPEAN HEART JOURNAL

Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study

(2020) Guang Yang et al.   HYPERTENSION

COVID-19: Abnormal liver function tests

(2020) Qingxian Cai et al.   JOURNAL OF HEPATOLOGY

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

(2020) Giuseppe Mancia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

(2020) Harmony R. Reynolds et al.   NEW ENGLAND JOURNAL OF MEDICINE

Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients

(2020) Gian Paolo Rossi et al.   eLife

Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?

(2020) Rami Sommerstein et al.   Journal of the American Heart Association

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers

(2020) Chirag Bavishi et al.   JAMA Cardiology

Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China

(2020) Juyi Li et al.   JAMA Cardiology

Use of RAAS Inhibitors and Risk of Clinical Deterioration in COVID-19: Results From an Italian Cohort of 133 Hypertensives

(2020) Carla Felice et al.   AMERICAN JOURNAL OF HYPERTENSION

Renin-Angiotensin System Blockers and the COVID-19 Pandemic

(2020) A.H. Jan Danser et al.   HYPERTENSION

The association between cardiac injury and outcomes in hospitalized patients with COVID-19

(2020) Shahrokh Karbalai Saleh et al.   Internal and Emergency Medicine

Covid-19: Male disadvantage highlights the importance of sex disaggregated data

(2020) Kate Womersley et al.   BMJ-British Medical Journal

Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis

(2016) Jonathan A. Silversides et al.   INTENSIVE CARE MEDICINE

Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study

(2016) Kathryn E Mansfield et al.   BMJ Open

Recommendations for the use of cardiac troponin measurement in acute cardiac care

(2010) K. Thygesen et al.   EUROPEAN HEART JOURNAL